Literature DB >> 16999940

Protection of nigral cell death by bilateral subthalamic nucleus stimulation.

Yasin Temel1, Veerle Visser-Vandewalle, Süleyman Kaplan, Ramazan Kozan, Marc A R C Daemen, Arjan Blokland, Christoph Schmitz, Harry W M Steinbusch.   

Abstract

In Parkinson disease (PD), the subthalamic nucleus (STN) becomes hyperactive (disinhibited), which is reported to cause excitotoxic damage to midbrain dopaminergic neurons. Here, we examined whether silencing of the hyperactive STN by chronic bilateral deep brain stimulation (DBS) increased the survival of midbrain dopaminergic neurons in a rat model of PD. High-precision design-based stereologic examination of the total number of neurons and tyrosine tydroxylase (TH) immunoreactive neurons in the substantia nigra pars compacta revealed that STN DBS resulted in a significant survival of these neurons. These data provide the first evidence in vivo that bilateral STN DBS is useful for protecting midbrain dopaminergic neurons from cell death in PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16999940     DOI: 10.1016/j.brainres.2006.08.082

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

Review 1.  Mechanisms of deep brain stimulation.

Authors:  Todd M Herrington; Jennifer J Cheng; Emad N Eskandar
Journal:  J Neurophysiol       Date:  2015-10-28       Impact factor: 2.714

2.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 3.  The 'current state of play' in transplantation and restoration research of the CNS.

Authors:  Dave J Eve; Paul R Sanberg
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 4.  Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.

Authors:  Amaal AlDakheel; Lorraine V Kalia; Anthony E Lang
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

5.  Dissociation between time reproduction of actions and of intervals in patients with Parkinson's disease.

Authors:  Diana Maria Elena Torta; Lorys Castelli; Luca Latini-Corazzini; Alessandra Banche; Leonardo Lopiano; Giuliano Geminiani
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

6.  Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial.

Authors:  P D Charles; R M Dolhun; C E Gill; T L Davis; M J Bliton; M G Tramontana; R M Salomon; L Wang; P Hedera; F T Phibbs; J S Neimat; P E Konrad
Journal:  Parkinsonism Relat Disord       Date:  2011-11-21       Impact factor: 4.891

7.  Electrical stimulation of the motor cortex enhances progenitor cell migration in the adult rat brain.

Authors:  Ali Jahanshahi; Lisa Schonfeld; Marcus L F Janssen; Sarah Hescham; Ersoy Kocabicak; Harry W M Steinbusch; Jacobus J van Overbeeke; Yasin Temel
Journal:  Exp Brain Res       Date:  2013-09-04       Impact factor: 1.972

Review 8.  Cell replacement therapy is the remedial solution for treating Parkinson's disease.

Authors:  Venkatesan Dhivya; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-06-30

Review 9.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

10.  Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease.

Authors:  Gian Pal; Bichun Ouyang; Leo Verhagen; Geidy Serrano; Holly A Shill; Charles H Adler; Thomas G Beach; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2018-01-30       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.